首页 › 胶质母细胞瘤 › 宾夕法尼亚州 › Pittsburgh
Pittsburgh PA 胶质母细胞瘤临床试验
9项针对 胶质母细胞瘤的研究正在 Pittsburgh及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
招募中3 期
- Allegheny Health Network, Pittsburgh
Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
招募中1/2 期
- UPMC Hillman Cancer Center, Pittsburgh
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
招募中2/3 期
- University of Pittsburgh Medical Center - Hillman Cancer Center, Pittsburgh
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
招募中2 期
- UPMC Hillman Cancer Center, Pittsburgh
Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
招募中1 期
- UPMC Hillman Cancer Center, Pittsburgh
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
招募中3 期
- UPMC Hillman Cancer Center, Pittsburgh
INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)
招募中2 期
- University of Pittsburgh Medical Center, Pittsburgh
DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)
招募中2 期
- UPMC Presbyterian Hospital, Pittsburgh
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
招募中1 期
- University of Pittsburg Medical Center (UPCM), Pittsburgh
其他城市的 胶质母细胞瘤试验
- New York City, NY30 项研究
- Boston, MA28 项研究
- Houston, TX26 项研究
- Los Angeles, CA24 项研究
- Durham, NC20 项研究
- San Francisco, CA17 项研究
- Chicago, IL15 项研究
- Washington, DC15 项研究
- Columbus, OH14 项研究
- Miami, FL14 项研究
- Rochester, MN13 项研究
- Jacksonville, FL13 项研究
Pittsburgh的其他研究
- 非小细胞肺癌48 项研究
- 癌症（所有类型）41 项研究
- 乳腺癌39 项研究
- 结直肠癌32 项研究
- 转移性癌症31 项研究
- 黑色素瘤31 项研究
- 卵巢癌30 项研究
- 子宫内膜癌23 项研究
- 前列腺癌23 项研究
- 肺癌23 项研究
- 头颈鳞状细胞癌22 项研究
- 卒中22 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。